Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of ARS Pharmaceuticals, Inc. (SPRY)

Go back to Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of ARS Pharmaceuticals, Inc. (SPRY)
(NASDAQ: SPRY) Delayed: 4.35 +0.24 (5.84%)
Previous Close $4.11    52 Week High
Open $4.16    52 Week Low
Day High $4.39    P/E N/A 
Day Low $4.07    EPS
Volume 1,197,964